Pharmaceutical Business Confidence Report Q1 2014

1
Pharmaceutical Business Confidence Report Q1
2014 www.bigmarketresearch.com
2
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Synopsis Pharmaceutical Business Confidence
Report Q1 2014 is a new report by Kable that
analyzes pharmaceutical industry executives
views on the global economy, expectations on
customer confidence, supplier prices, key
business concerns, and how executives future
investments are set to change in Q1 2014. This
report also gives you access to regional analysis
of industry outlook, industry and company growth
prospects, future opportunities, staff hiring,
and sales performance. Apart from providing
access to the opinions and strategies of global
pharmaceutical industry executives, it also
examines their actions surrounding business
priorities, threats and opportunities, and future
investment areas over the next six months.
Moreover, this report provides a comparative
analysis of survey results with Q4 2013 wherever
applicable. Read complete report here _at_
http//www.bigmarketresearch.com/pharmaceutical-bu
siness-confidence-report-q1-2014-market
3
Acquired (Autoimmune) Hemolytic Anemia
Report Description

• Scope
• Project industry trends and industry growth
  expectations in the next six months, and
  understand business confidence to make informed
  business decisions.
• The report drives revenues by understanding
  future product investment areas and key growth
  regions.
• Readers will be provided with a clear uncovering
  of key challenges and opportunities, and identify
  the key priorities likely to affect growth
  prospects of the industry.
• The report clearly forecasts the change in
  supplier prices for various products, which are
  likely to influence the industrys growth
  prospects over the next six months.
• Identifies the major changes in customer
  confidence levels in the pharmaceutical industry
  over the next six months.

4
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Summary Why was the report written? This report
is the result of an extensive survey drawn from
Kables exclusive panel of leading global
pharmaceutical industry executives. The report
analyzes current economic conditions prevailing
across the globe and their impact on the
pharmaceutical industry, and forecasts company
and industry growth prospects over the next six
months. Furthermore, it provides information
about the impact of customer confidence, supplier
prices, and staff headcount likely to affect the
investment decisions of the industry over the
next six months. Additionally, this report tracks
the change in executives perceptions during the
last three months, by providing a comparative
analysis of survey results with the previous
quarter. What is the current market landscape and
what is changing? Overall, 74 and 60 of global
pharmaceutical industry executives are optimistic
about the future growth prospects of both their
company and the industry, respectively, over the
next six months. Optimism towards company and
industry growth prospects has improved by eight
and ten percentage points, respectively, in Q1
2014, compared to Q4 2013 results.
5
Acquired (Autoimmune) Hemolytic Anemia
Report Description
Summary What are the key drivers behind recent
market changes? Optimism towards industry and
company growth is driven by the improving global
economic conditions, investments in emerging
markets, and the introduction of new products in
the market. What makes this report unique and
essential to read? Pharmaceutical Business
Confidence Report Q1 2014 is a new report by
Kable that analyzes the industry sentiments
globally on the latest economic and customer
issues and their impact upon investment decisions
and growth prospects within the pharmaceutical
industry. This report also examines the executive
opinion about the current and future state of the
economy and its retrospective effect on the
industry. Furthermore, it analyzes the likely
effect of supplier price changes, sales
performance, and staff headcount within the
industry over the next six months. In addition,
it provides an overview of the key priorities,
threats, and opportunities for the global
pharmaceutical industry over the next six months.
Furthermore, it also tracks the change in
industry executives thought process, by
providing a comparative analysis of survey
results with Q4 2013, wherever applicable.
6
Report Description

• Reasons To Buy
• According to pharmaceutical industry respondents,
  the present economic conditions in Africa and the
  Middle East are deemed to be unfavourable. In the
  Q4 2013 survey, similar opinions were recorded.
• New government proposals/legislation, competition
  from new entrants, state of global economy, and
  performance of the Eurozone are the key concerns
  among global pharmaceutical industry executives.
• Enquire about this report _at_ http//www.bigmarketre
  search.com/report-enquiry/110033

7
Report Description

• Reasons To Buy
• Survey respondents forecast that supplier prices
  for raw materials will increase at an average of
  4.1, with those from Asia-Pacific expecting the
  biggest rise.
• In total, 52 of global pharmaceutical industry
  executives anticipate either no change or a
  negative change in customer confidence over the
  industry, in the next six months.
• Industry executives exhibit high levels of
  optimism towards company growth prospects
  compared to industry growth prospects, in the
  next six months

8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/pharmaceutical-bu
siness-confidence-report-q1-2014-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com